{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:32:20Z","timestamp":1761535940350,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["121943"],"award-info":[{"award-number":["121943"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1111\/jth.15502","type":"journal-article","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T04:23:23Z","timestamp":1629347003000},"page":"3168-3176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["von Willebrand factor propeptide\u2010to\u2010antigen ratio in HIV\u2010infected pregnancy: Evidence of endothelial activation"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1534-2930","authenticated-orcid":false,"given":"Elise","family":"Schapkaitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Libhaber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry F.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muriel","family":"Meiring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry R.","family":"B\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1111\/jth.15502_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199555","article-title":"Pregnancy outcomes among HIV\u2010infected women who conceived on antiretroviral therapy","volume":"13","author":"Stringer","year":"2018","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1111\/jth.15502_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(16)30195-3","article-title":"Timing of initiation of antiretroviral therapy and adverse pregnancy outcomes: a systematic review and meta\u2010analysis","volume":"4","author":"Uthman","year":"2017","journal-title":"Lancet HIV"},{"issue":"2","key":"10.1111\/jth.15502_bb0020","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa805","article-title":"Pregnancy outcomes of women conceiving on antiretroviral therapy (ART) compared to those commenced on ART during pregnancy","volume":"73","author":"Theron","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1111\/jth.15502_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(18)30333-3","article-title":"Incidence of a first venous thrombotic event in people with HIV in the Netherlands: a retrospective cohort study","volume":"6","author":"Howard","year":"2019","journal-title":"Lancet HIV"},{"issue":"1","key":"10.1111\/jth.15502_bb0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MBC.0b013e3282f38c23","article-title":"Venous thromboembolism in HIV\u2010positive women during puerperium: a case series","volume":"19","author":"Jansen","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.15502_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/ijgo.13596","article-title":"Pregnancy\u2010related venous thromboembolism and HIV infection","author":"Schapkaitz","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"10.1111\/jth.15502_bb0040","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/QAD.0b013e3283453fcb","article-title":"Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV","volume":"25","author":"Musselwhite","year":"2011","journal-title":"Aids"},{"key":"10.1111\/jth.15502_bb0045","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fmicb.2015.00180","article-title":"von Willebrand Factor is elevated in HIV patients with a history of thrombosis","volume":"6","author":"van den Dries","year":"2015","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1111\/jth.15502_bb0050","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1182\/blood-2009-03-210179","article-title":"Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation","volume":"115","author":"Funderburg","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1111\/jth.15502_bb0055","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/QAD.0000000000000545","article-title":"The effect of HAART\u2010induced HIV suppression on circulating markers of inflammation and immune activation","volume":"29","author":"Wada","year":"2015","journal-title":"Aids"},{"issue":"1","key":"10.1111\/jth.15502_bb0060","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/QAI.0000000000002633","article-title":"Plasmatic coagulation capacity correlates with inflammation and abacavir\u2010use during chronic HIV\u2010infection","volume":"87","author":"van der Heijden","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"10.1111\/jth.15502_bb0065","first-page":"1228","article-title":"The effect of initiating combined antiretroviral therapy on endothelial cell activation and coagulation markers in South African HIV\u2010infected individuals","volume":"104","author":"Jong","year":"2010","journal-title":"Thromb Haemost"},{"issue":"12","key":"10.1111\/jth.15502_bb0070","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection","volume":"201","author":"Neuhaus","year":"2010","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1111\/jth.15502_bb0075","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1097\/QAD.0b013e32833ad914","article-title":"Traditional risk factors and D\u2010dimer predict incident cardiovascular disease events in chronic HIV infection","volume":"24","author":"Ford","year":"2010","journal-title":"Aids"},{"issue":"1","key":"10.1111\/jth.15502_bb0080","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/QAI.0000000000002533","article-title":"Association of plasma soluble vascular cell adhesion molecule\u20101 and sCD14 with mortality in HIV\u20101\u2010infected west african adults with high CD4 counts","volume":"86","author":"Affi","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"13","key":"10.1111\/jth.15502_bb0085","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1097\/QAD.0000000000002305","article-title":"Inflammatory biomarkers prior to antiretroviral therapy as prognostic markers of 12\u2010month mortality in South Africa and Uganda","volume":"33","author":"Siedner","year":"2019","journal-title":"Aids"},{"issue":"8","key":"10.1111\/jth.15502_bb0090","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/MBC.0b013e3282f1012d","article-title":"Effect of antiretroviral therapy on hemostasis in Brazilian pregnant women with HIV infection","volume":"18","author":"de Andrade","year":"2007","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"12","key":"10.1111\/jth.15502_bb0095","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1111\/j.1538-7836.2006.02205.x","article-title":"Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome","volume":"4","author":"Hulstein","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15502_bb0100","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.cb.06.110190.001245","article-title":"Cell biology of von Willebrand factor","volume":"6","author":"Wagner","year":"1990","journal-title":"Annu Rev Cell Biol"},{"issue":"8","key":"10.1111\/jth.15502_bb0105","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1182\/blood.V88.8.2951.bloodjournal8882951","article-title":"Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1\u2010deamino\u20108\u2010D\u2010arginine vasopressin in humans","volume":"88","author":"Borchiellini","year":"1996","journal-title":"Blood"},{"issue":"11","key":"10.1111\/jth.15502_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112935","article-title":"Complex changes in von Willebrand factor\u2010associated parameters are acquired during uncomplicated pregnancy","volume":"9","author":"Drury\u2010Stewart","year":"2014","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1111\/jth.15502_bb0115","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1046\/j.1365-2141.2003.04371.x","article-title":"Reassessment of von Willebrand factor (VWF), VWF propeptide, factor VIII: C and plasminogen activator inhibitors 1 and 2 during normal pregnancy","volume":"121","author":"Sie","year":"2003","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1111\/jth.15502_bb0120","first-page":"36","article-title":"Verification of a rapid von Willebrand factor propeptide assay","volume":"2","author":"Maleka","year":"2020","journal-title":"J Med Lab Sci Technol South Africa"},{"issue":"2","key":"10.1111\/jth.15502_bb0125","first-page":"16","article-title":"A rapid and cost\u2010effective method to visualize von Willebrand factor multimers in plasma","volume":"19","author":"Meiring","year":"2005","journal-title":"Medical Technology SA"},{"issue":"12","key":"10.1111\/jth.15502_bb0130","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1111\/j.1538-7836.2006.02273.x","article-title":"von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis","volume":"4","author":"Nossent","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1111\/jth.15502_bb0135","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1182\/blood.V94.1.179.413k18_179_185","article-title":"von Willebrand factor propeptide in vascular disorders: A tool to distinguish between acute and chronic endothelial cell perturbation","volume":"94","author":"van Mourik","year":"1999","journal-title":"Blood"},{"issue":"11","key":"10.1111\/jth.15502_bb0140","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1016\/S0021-9258(18)83304-X","article-title":"Inhibition of platelet\u2010collagen interaction by propolypeptide of von Willebrand factor","volume":"264","author":"Takagi","year":"1989","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1111\/jth.15502_bb0145","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1083\/jcb.145.2.413","article-title":"The integrin alpha9beta1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule\u20101","volume":"145","author":"Taooka","year":"1999","journal-title":"J Cell Biol"},{"issue":"3","key":"10.1111\/jth.15502_bb0150","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5830\/CVJA-2018-003","article-title":"HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long\u2010term antiretroviral therapy in Botswana","volume":"29","author":"Mosepele","year":"2018","journal-title":"Cardiovasc J Afr"},{"key":"10.1111\/jth.15502_bb0155","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/1471-2334-13-263","article-title":"A prospective study of endothelial activation biomarkers, including plasma angiopoietin\u20101 and angiopoietin\u20102, in Kenyan women initiating antiretroviral therapy","volume":"13","author":"Graham","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"11","key":"10.1111\/jth.15502_bb0160","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1097\/QAD.0000000000000675","article-title":"The effect of short\u2010course antiretroviral therapy initiated in primary HIV\u20101 infection on interleukin\u20106 and D\u2010dimer levels","volume":"29","author":"Hamlyn","year":"2015","journal-title":"Aids"},{"issue":"5","key":"10.1111\/jth.15502_bb0165","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/QAI.0000000000001629","article-title":"Brief report: higher ART adherence is associated with lower systemic inflammation in treatment\u2010naive ugandans who achieve virologic suppression","volume":"77","author":"Castillo\u2010Mancilla","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"10.1111\/jth.15502_bb0170","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/hiv.12665","article-title":"Longitudinal evaluation of markers of inflammation in HIV\u2010positive and HIV\u2010negative Rwandan women","volume":"19","author":"Kiefer","year":"2018","journal-title":"HIV Med"},{"issue":"1","key":"10.1111\/jth.15502_bb0175","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/s12879-020-05213-1","article-title":"Changes in D\u2010dimer after initiation of antiretroviral therapy in adults living with HIV in Kenya","volume":"20","author":"Teasdale","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1111\/jth.15502_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214735","article-title":"Inflammatory biomarkers and subclinical carotid atherosclerosis in HIV\u2010infected and HIV\u2010uninfected men in the Multicenter AIDS Cohort Study","volume":"14","author":"Subramanya","year":"2019","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1111\/jth.15502_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152588","article-title":"D\u2010dimer levels before HIV seroconversion remain elevated even after viral suppression and are associated with an increased risk of non\u2010AIDS events","volume":"11","author":"Freiberg","year":"2016","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1111\/jth.15502_bb0190","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx262","article-title":"Systemic inflammation, coagulation, and clinical risk in the START trial","volume":"4","author":"Baker","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"10.1111\/jth.15502_bb0195","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/cid\/ciy253","article-title":"Intestinal barrier dysfunction and microbial translocation in human immunodeficiency virus\u2010infected pregnant women are associated with preterm birth","volume":"67","author":"Shivakoti","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1111\/jth.15502_bb0200","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/infdis\/jiv416","article-title":"Inflammatory markers related to microbial translocation among HIV\u2010infected pregnant women: a risk factor of preterm delivery","volume":"213","author":"Lopez","year":"2016","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1111\/jth.15502_bb0205","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial translocation is a cause of systemic immune activation in chronic HIV infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat Med"},{"issue":"12","key":"10.1111\/jth.15502_bb0210","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1471-0528.1977.tb12521.x","article-title":"Factor VIII\u2010related antigen and factor VIII coagulant activity in normal and pre\u2010eclamptic pregnancy","volume":"84","author":"Thornton","year":"1977","journal-title":"Br J Obstet Gynaecol"},{"issue":"6","key":"10.1111\/jth.15502_bb0215","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1182\/blood.V98.6.1654","article-title":"Partial amino acid sequence of purified von Willebrand factor\u2010cleaving protease","volume":"98","author":"Gerritsen","year":"2001","journal-title":"Blood"},{"issue":"1","key":"10.1111\/jth.15502_bb0220","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2004-01-0107","article-title":"Effects of inflammatory cytokines on the release and cleavage of the endothelial cell\u2010derived ultralarge von Willebrand factor multimers under flow","volume":"104","author":"Bernardo","year":"2004","journal-title":"Blood"},{"issue":"11","key":"10.1111\/jth.15502_bb0225","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1111\/j.1538-7836.2007.02743.x","article-title":"von Willebrand factor and related parameters in severe sepsis and septic shock","volume":"5","author":"Kremer Hovinga","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"8","key":"10.1111\/jth.15502_bb0230","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1086\/597471","article-title":"Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura","volume":"48","author":"Benjamin","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1111\/jth.15502_bb0235","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1111\/j.1537-2995.2007.01346.x","article-title":"ADAMTS13 activity and the presence of acquired inhibitors in human immunodeficiency virus\u2010related thrombotic thrombocytopenic purpura","volume":"47","author":"Gunther","year":"2007","journal-title":"Transfusion"},{"issue":"2","key":"10.1111\/jth.15502_bb0240","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7150\/ijms.28110","article-title":"Von Willebrand factor adhesive activity and ADAMTS13 protease activity in HIV\u20101\u2010infected men","volume":"16","author":"Graham","year":"2019","journal-title":"Int J Med Sci"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15502","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15502","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622005372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622005372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:28:07Z","timestamp":1761535687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622005372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1538783622005372"],"URL":"https:\/\/doi.org\/10.1111\/jth.15502","relation":{},"ISSN":["1538-7836"],"issn-type":[{"type":"print","value":"1538-7836"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"von Willebrand factor propeptide\u2010to\u2010antigen ratio in HIV\u2010infected pregnancy: Evidence of endothelial activation","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15502","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}